NL-OMON27088已完成不适用
Treatment of bone loss and changes in bone architecture in osteopenic patients with Crohn's disease; a comparison between calcium supplementation and vitamin D alone or combined with oral Risedronate 35 mg once weekly.
Aventis0 个研究点目标入组 130 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Men and women „d 18 < 70 years of age;
排除标准
- •1. Patients with a DXA T-score < -2.5 in lumbar spine or total hip;
研究者
相似试验
已完成
不适用
Treatment of bone loss and changes in bone architecture in osteopenic patients with Crohn's disease: a comparison between calcium supplementation and vitamin D alone or combined with oral risedronate 35 mg once weeklyCrohn's, OsteopeniaDigestive SystemNoninfective enteritisISRCTN59682218Aventis (The Netherlands)130
招募中
不适用
Clinical investigation of change of bone-related marker between denosumab and zoledronic acid in patients with treatment-naive,bone-metastasis prostate cancer:prospective, multiinstitutional,cohort studytreatment-naive prostate cancer with bone metastasisJPRN-UMIN000018268Department of Renal and Urologic Surgery, Asahikawa Medical University50
暂停
不适用
Elucidation of pathologic condition in bone and calcification using F-18 NaF PETPatients with or suspected bone and soft tissue tumor or arteriosclerosisJPRN-UMIN000043743Kagawa University100
已完成
不适用
Analyses of factors involved in bone remodeling and inflammation in Ankylosing Spondylitis (AS) patients undergoing etanercept therapyM45.00DRKS00004838Rheumazentrum Prof. Dr. med. G. Neeck56
尚未招募
不适用
Prophylactic Reinforcement of Osteoporotic Bone in Elderly.patients with a fresh, low energy, fracture of the hipheupfracturenpreventieosteoporoseNL-OMON24464none100